Week in review: Mindfulness for visual snow, barriers to diabetes eye care, FDA rejects reproxalap
- Posted on: Dec 1 2023
- Leave a response
A vision-oriented mindfulness program appears to improve the impact of visual snow syndrome, certain factors may prevent those with diabetes from seeking eye care, the FDA rejects reproxalap for dry eye disease, and patients with myopia may see a reduced risk of diabetic retinopathy.
Source: AAO
Posted in: Uncategorized
